Medicine Man Technologies Reports Officer/Director Changes & Financials

Medicine Man Technologies, Inc. 8-K Filing Summary
FieldDetail
CompanyMedicine Man Technologies, Inc.
Form Type8-K
Filed DateMay 6, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: management-change, compensation, financials

TL;DR

Med Man Tech (MDMG) filed 8-K: new execs, comp details, and financials out.

AI Summary

Medicine Man Technologies, Inc. filed an 8-K on May 6, 2025, reporting events as of April 30, 2025. The filing indicates changes related to directors and officers, including elections and appointments, as well as details on compensatory arrangements for certain officers. It also includes financial statements and exhibits.

Why It Matters

This filing provides insight into the company's leadership structure and compensation, which can impact strategic direction and investor confidence.

Risk Assessment

Risk Level: medium — Changes in directors and officers, along with financial reporting, can signal shifts in company strategy or performance, warranting closer investor scrutiny.

Key Players & Entities

  • Medicine Man Technologies, Inc. (company) — Registrant
  • Nevada (jurisdiction) — State of Incorporation
  • 865 N. Albion St. Suite 300 Denver, CO 80220 (address) — Principal Executive Offices
  • April 30, 2025 (date) — Date of earliest event reported
  • May 6, 2025 (date) — Filing Date

FAQ

What specific changes were made regarding directors or officers?

The filing indicates "Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers" as an item of report, suggesting changes in leadership roles.

What type of compensatory arrangements are detailed in the filing?

The filing mentions "Compensatory Arrangements of Certain Officers," implying details about executive compensation are provided.

What financial information is included in this 8-K?

The filing explicitly lists "Financial Statements and Exhibits" as an item of report.

When was the earliest event reported in this filing?

The earliest event reported was as of April 30, 2025.

What is the principal business address of Medicine Man Technologies, Inc.?

The principal executive offices are located at 865 N. Albion St. Suite 300, Denver, CO 80220.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 6, 2025 regarding Medicine Man Technologies, Inc..

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.